Encompass Health/$EHC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Encompass Health
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
Ticker
$EHC
Sector
Primary listing
NYSE
Employees
29,198
Headquarters
Website
Encompass Health Metrics
BasicAdvanced
$11B
21.51
$5.29
0.80
$0.70
0.67%
Price and volume
Market cap
$11B
Beta
0.8
52-week high
$127.99
52-week low
$87.85
Average daily volume
740K
Dividend rate
$0.70
Financial strength
Current ratio
1.141
Quick ratio
0.865
Long term debt to equity
81.496
Total debt to equity
83.533
Dividend payout ratio (TTM)
12.77%
Interest coverage (TTM)
8.03%
Profitability
EBITDA (TTM)
1,331.9
Gross margin (TTM)
42.65%
Net profit margin (TTM)
9.33%
Operating margin (TTM)
17.47%
Effective tax rate (TTM)
19.53%
Revenue per employee (TTM)
$200,000
Management effectiveness
Return on assets (TTM)
9.50%
Return on equity (TTM)
24.41%
Valuation
Price to earnings (TTM)
21.511
Price to revenue (TTM)
1.971
Price to book
4.82
Price to tangible book (TTM)
14.69
Price to free cash flow (TTM)
28.378
Free cash flow yield (TTM)
3.52%
Free cash flow per share (TTM)
4.012
Dividend yield (TTM)
0.61%
Forward dividend yield
0.67%
Growth
Revenue change (TTM)
11.13%
Earnings per share change (TTM)
27.87%
3-year revenue growth (CAGR)
10.86%
10-year revenue growth (CAGR)
7.33%
3-year earnings per share growth (CAGR)
24.81%
10-year earnings per share growth (CAGR)
11.08%
3-year dividend per share growth (CAGR)
-10.91%
10-year dividend per share growth (CAGR)
-2.04%
What the Analysts think about Encompass Health
Analyst ratings (Buy, Hold, Sell) for Encompass Health stock.
Bulls say / Bears say
Net operating revenue grew 12.0% year-over-year to $1,457.7 million in Q2 2025 while adjusted EPS rose 26.1% to $1.40, supported by 7.2% discharge growth and 4.2% pricing gains. (PRNewswire)
Management raised the full-year 2025 outlook, increasing revenue guidance to $5,880 million–$5,980 million and adjusted EBITDA guidance to $1,220 million–$1,250 million, signaling confidence in continued growth. (PRNewswire)
In Q2 2025, Encompass Health boosted capacity by opening a new 60-bed hospital in Fort Myers, Florida, and adding 26 beds to an existing hospital, supporting future revenue growth. (PRNewswire)
As of June 30, 2025, Encompass Health had net long-term debt of $2.32 billion compared to shareholders’ equity of $2.28 billion, resulting in a debt-to-equity ratio above 1.0x that could limit financial flexibility as interest rates rise. (PRNewswire)
Encompass Health projects $785 million to $820 million in capital expenditures for 2025, including roughly $380 million for projects in progress, which may put pressure on free cash flow and increase dependence on debt financing. (SEC)
The CMS proposal to widen coverage of home-based health services could divert patient volume from inpatient rehabilitation hospitals like Encompass Health, potentially lowering discharges and revenue. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 9 Oct 2025.
Encompass Health Financial Performance
Revenues and expenses
Encompass Health Earnings Performance
Company profitability
Encompass Health News
AllArticlesVideos
Rosen Law Firm Encourages Encompass Health Corporation Investors to Inquire About Securities Class Action Investigation – EHC
Business Wire2 weeks ago
Johnson Fistel Investigates Encompass Health Following Reports of Poor Patient Outcomes at Rehab Facilities
Business Wire2 months ago
Rosen Law Firm Encourages Encompass Health Corporation Investors to Inquire About Securities Class Action Investigation – EHC
Business Wire2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Encompass Health stock?
Encompass Health (EHC) has a market cap of $11B as of November 01, 2025.
What is the P/E ratio for Encompass Health stock?
The price to earnings (P/E) ratio for Encompass Health (EHC) stock is 21.51 as of November 01, 2025.
Does Encompass Health stock pay dividends?
Yes, the Encompass Health (EHC) stock pays dividends to shareholders. As of November 01, 2025, the dividend rate is $0.7 and the yield is 0.67%. Encompass Health has a payout ratio of 12.77% on a trailing twelve-month basis.
When is the next Encompass Health dividend payment date?
The next Encompass Health (EHC) dividend payment is scheduled for January 15, 2026.
What is the beta indicator for Encompass Health?
Encompass Health (EHC) has a beta rating of 0.8. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.